Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties.
BSX has been the topic of several other reports. The company's outstanding shares are 420.07 Million. The beta factor is 0.90.Volatility shows sense of how far the stock will fall if the market takes a dive and how high stock will rise if the bull starts to climb. BidaskClub lowered shares of Boston Scientific Corporation from a "buy" rating to a "hold" rating in a report on Tuesday, July 25th. 19 of them rate its stock a hold. Finally, Needham & Company LLC upgraded shares of Boston Scientific from a buy rating to a strong-buy rating and upped their price target for the company from $25.04 to $32.00 in a report on Friday, December 8th. One analyst has rated the stock with a sell rating, five have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company's stock. The company has an average rating of "Buy" and a consensus target price of $31.00.
Shares of Boston Scientific Corporation (NYSE BSX) opened at $26.11 on Wednesday.
Boston Scientific Corporation (NYSE:BSX) and Hologic, Inc.
The company has a quick ratio of 0.50, a current ratio of 0.72 and a debt-to-equity ratio of 0.58. The company operates in the Healthcare sector with a market capitalization of 35.82 Million.
Price earnings ratio (P/E) ratio of Boston Scientific Corporation (BSX) is 378.41.
Boston Scientific Corporation (NYSE:BSX) reported its EPS in the last quarter as $0.34/Share lagging the analyst estimate of $0.34/Share by a difference of $0.
EPS Estimate for the next year is 1.55. The business's revenue for the quarter was up 9.9% on a year-over-year basis. research analysts forecast that Boston Scientific Corporation will post 1.37 earnings per share for the current year.
First we'll look at Return on Assets or ROA, Boston Scientific Corp (BSX) has a current ROA of 4.64. A low price-to-sales ratio, typically less than 1.0, is considered a good value. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Now we look at the Moving Averages, the 200-day is -4.79%, the 50-day is -0.91% and the 20-day is -4.27%. Following the transaction, the executive vice president now owns 174,681 shares in the company, valued at approximately $5,107,672.44. The disclosure for this sale can be found here. Sit Investment Associates Inc. now owns 141,710 shares of the medical equipment provider's stock worth $4,134,000 after purchasing an additional 38,855 shares in the last quarter. Prelude Cap Ltd Limited Liability Company invested 0.12% in Boston Scientific Corporation (NYSE:BSX).
A number of brokerages have recently commented on BSX. LLC acquired a new stake in shares of Boston Scientific in the 2nd quarter valued at about $40,460,000.
More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: Nasdaq.com which released: "Millipede to Aid Boston Scientific, LOTUS Relaunch Lag Ails" on February 06, 2018, also Prnewswire.com with their article: "Boston Scientific to Participate in LEERINK Partners 7th Annual Global ..." published on January 24, 2018, Prnewswire.com published: "Boston Scientific Announces Updated Time For Webcast Conference Call ..." on January 19, 2018. Cerebellum GP LLC purchased a new stake in Boston Scientific during the fourth quarter worth $126,000.
Sirios Capital Management LP increased Boston Scientific Corp (BSX) stake by 373.54% reported in 2017Q3 SEC filing. Oppenheimer Holdings, Inc. reissued a "hold" rating on shares of Boston Scientific Corporation in a report on Wednesday, June 28th.
Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments.
ILLEGAL ACTIVITY NOTICE: This piece was posted by StockNewsTimes and is owned by of StockNewsTimes.
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world.